Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Gevo
GEVO
$382M
| $3.78M | ﹤0.01% |
4,923,049
-275,487
| -5% | -$240K |
|
|
THRD
2852
DELISTED
Third Harmonic Bio
THRD
| $3.78M | ﹤0.01% |
400,068
-625
| -0.2% | -$6.08K |
|
2853
Alamos Gold
AGI
$13.9B
| $3.77M | ﹤0.01% |
248,376
+15,050
| +6% | +$190K |
|
2854
eHealth
EHTH
$43.9M
| $3.77M | ﹤0.01% |
624,408
+13,222
| +2% | +$87.7K |
|
2855
Jasper Therapeutics
JSPR
$23.6M
| $3.76M | ﹤0.01% |
127,991
+37,543
| +42% | +$667K |
|
2856
Vodafone
VOD
$37.4B
| $3.75M | ﹤0.01% |
421,429
+5,534
| +1% | +$48.1K |
|
2857
First Internet Bancorp
INBK
$255M
| $3.74M | ﹤0.01% |
107,688
+1,466
| +1% | +$44.4K |
|
2858
B2Gold
BTG
$6.64B
| $3.73M | ﹤0.01% |
1,307,103
-375,378
| -22% | -$1.01M |
|
2859
Tredegar Corp
TG
$310M
| $3.71M | ﹤0.01% |
569,007
-2,165
| -0.4% | -$10.5K |
|
2860
BCB Bancorp
BCBP
$161M
| $3.7M | ﹤0.01% |
354,406
+14,642
| +4% | +$167K |
|
2861
Eos Energy Enterprises
EOSE
$1.51B
| $3.69M | ﹤0.01% |
3,579,688
+856,471
| +31% | +$871K |
|
2862
Innodata
INOD
$2.04B
| $3.67M | ﹤0.01% |
556,415
+24,694
| +5% | +$205K |
|
|
SRTA
2863
Strata Critical Medical Inc
SRTA
$512M
| $3.67M | ﹤0.01% |
1,286,957
+12,615
| +1% | +$38.9K |
|
|
DFTX
2864
Definium Therapeutics
DFTX
$6.12B
| $3.66M | ﹤0.01% |
389,404
+11,489
| +3% | +$65.5K |
|
2865
Safe Bulkers
SB
$774M
| $3.64M | ﹤0.01% |
733,911
+5,808
| +0.8% | +$25.6K |
|
2866
Gencor Industries
GENC
$212M
| $3.64M | ﹤0.01% |
218,005
+8,993
| +4% | +$145K |
|
2867
RGC Resources
RGCO
$228M
| $3.64M | ﹤0.01% |
179,690
+11,670
| +7% | +$226K |
|
2868
Backblaze
BLZE
$1.16B
| $3.64M | ﹤0.01% |
355,276
+10,059
| +3% | +$93K |
|
2869
Harvard Bioscience
HBIO
$29.2M
| $3.63M | ﹤0.01% |
85,622
+5,158
| +6% | +$232K |
|
2870
Vera Bradley
VRA
$98.7M
| $3.63M | ﹤0.01% |
533,679
+17,510
| +3% | +$128K |
|
2871
Latham Group
SWIM
$880M
| $3.62M | ﹤0.01% |
914,498
+6,077
| +0.7% | +$17.3K |
|
|
KEEL
2872
Keel Infrastructure Corp
KEEL
$2.34B
| $3.61M | ﹤0.01% |
1,619,091
+110,938
| +7% | +$288K |
|
2873
Star Holdings Shares of Beneficial Interest
STHO
$116M
| $3.56M | ﹤0.01% |
275,459
-8,088
| -3% | -$101K |
|
2874
LanzaTech
LNZA
$69.8M
| $3.56M | ﹤0.01% |
11,494
+263
| +2% | +$97.7K |
|
2875
Oak Valley Bancorp
OVLY
$281M
| $3.55M | ﹤0.01% |
143,158
+4,101
| +3% | +$104K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.